Professional Media briefs

Dove Medical Press announced the appointment of Dr. Jerry Bagel as the editor-in-chief of its new journal, Psoriasis: Targets and Therapy. This international, peer-reviewed open-access journal focuses on therapies for psoriasis. Bagel, a nationally recognized expert in the treatment of psoriasis, is also director of the Psoriasis Treatment Center of Central New Jersey in East Windsor. 

Elsevier has launched an iPhone and iPad app version of its signature cardiology and heart disease textbook Brunwald's Heart Disease: A Textbook of Cardiovascular Medicine called Brunwald's Heart Disease Practice Guide. The app, which makes available content from the 9th edition of the global cardiology publication, provides up-to-date, evidence-based cardiology clinical practice guidelines from the American College of Cardiology and the American Heart Association.

BMJ Group appointed Seema Biswas as editor-in-chief of BMJ Case Reports, which is home to the largest single collection of medical case reports on the web, encompassing more than 2,500 published contributions in every discipline. Biswas, has held the post of lead clinical editor for onExamination, a tool produced by BMJ Learning, since May 2010.

You must be a registered member of MMM to post a comment.

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.